Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Free Cash Flow Generation Index
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Free Cash Flow Generation Index of 0.47x as of December 2025. Free cash flow of CN¥1.12 Billion represents 0% of operating cash flow (CN¥2.40 Billion). Read 600196 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Fosun Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Explore 600196 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Fosun Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Shanghai Fosun Pharmaceutical Group Co L market cap and net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | CN¥1.56 Billion | CN¥6.01 Billion | CN¥4.45 Billion | ▲ +1637.7% |
| 2024 | 0.01x | CN¥66.79 Million | CN¥4.48 Billion | CN¥4.41 Billion | ▲ +103.4% |
| 2023 | -0.44x | CN¥-1.92 Billion | CN¥4.36 Billion | CN¥5.34 Billion | ▼ -11.2% |
| 2022 | -0.40x | CN¥-1.67 Billion | CN¥4.22 Billion | CN¥5.89 Billion | ▼ -52.8% |
| 2021 | -0.26x | CN¥-1.02 Billion | CN¥3.95 Billion | CN¥4.97 Billion | ▲ +64.0% |
| 2020 | -0.72x | CN¥-1.86 Billion | CN¥2.58 Billion | CN¥4.44 Billion | ▼ -213.7% |
| 2019 | -0.23x | CN¥-739.65 Million | CN¥3.22 Billion | CN¥3.96 Billion | ▼ -201.2% |
| 2018 | -0.08x | CN¥-224.81 Million | CN¥2.95 Billion | CN¥3.17 Billion | ▼ -148.0% |
| 2017 | 0.16x | CN¥409.61 Million | CN¥2.58 Billion | CN¥2.17 Billion | ▲ +78.1% |
| 2016 | 0.09x | CN¥188.08 Million | CN¥2.11 Billion | CN¥1.92 Billion | ▼ -62.5% |
| 2015 | 0.24x | CN¥385.49 Million | CN¥1.62 Billion | CN¥1.24 Billion | ▲ +253.3% |
| 2014 | 0.07x | CN¥80.78 Million | CN¥1.20 Billion | CN¥1.12 Billion | ▲ +339.6% |
| 2013 | -0.03x | CN¥-28.42 Million | CN¥1.01 Billion | CN¥1.04 Billion | ▲ +96.2% |
| 2012 | -0.74x | CN¥-495.08 Million | CN¥665.52 Million | CN¥1.16 Billion | ▲ +50.9% |
| 2011 | -1.52x | CN¥-480.18 Million | CN¥316.65 Million | CN¥796.83 Million | ▼ -127.1% |
| 2010 | -0.67x | CN¥-135.81 Million | CN¥203.36 Million | CN¥339.17 Million | ▼ -102.9% |
| 2009 | -0.33x | CN¥-86.20 Million | CN¥261.87 Million | CN¥348.07 Million | ▼ -442.3% |
| 2008 | 0.10x | CN¥22.41 Million | CN¥233.04 Million | CN¥210.63 Million | ▲ +116.2% |
| 2007 | -0.59x | CN¥-78.23 Million | CN¥131.48 Million | CN¥209.71 Million | ▼ -34.7% |
| 2006 | -0.44x | CN¥-81.69 Million | CN¥184.91 Million | CN¥266.61 Million | ▼ -142.9% |
| 2005 | -0.18x | CN¥-34.26 Million | CN¥188.35 Million | CN¥222.60 Million | ▼ -43884.5% |
| 2004 | 0.00x | CN¥85.20K | CN¥205.10 Million | CN¥205.02 Million | ▲ +100.1% |
| 2003 | -0.76x | CN¥-113.92 Million | CN¥150.14 Million | CN¥264.05 Million | ▼ -109.9% |
| 2002 | -0.36x | CN¥-37.05 Million | CN¥102.47 Million | CN¥139.52 Million | ▲ +66.4% |
| 2001 | -1.08x | CN¥-73.35 Million | CN¥68.15 Million | CN¥141.51 Million | ▼ -1362.5% |
| 2000 | 0.09x | CN¥11.80 Million | CN¥138.43 Million | CN¥126.63 Million | ▲ +108.2% |
| 1999 | -1.04x | CN¥-39.79 Million | CN¥38.20 Million | CN¥77.99 Million | ▼ -584.7% |
| 1998 | 0.21x | CN¥14.30 Million | CN¥66.55 Million | CN¥52.25 Million | — |